Company intelligence / Profile preview

Qeen Biotechnologies

Istanbul, Istanbul, Turkey

Ownership: Private
Development stage: Other

Overview

Qeen Biotechnologies is a biotechnology company focused on developing advanced regenerative medicine solutions using stem cell and exosome technologies. The company leverages its proprietary platform to create therapeutic products aimed at treating degenerative conditions, autoimmune diseases, and chronic wounds. Their research emphasizes the use of mesenchymal stem cells (MSCs) and their derivatives to promote tissue repair and modulate immune responses. Qeen Biotechnologies aims to bridge the gap between laboratory research and clinical application to provide innovative treatments for unmet medical needs.

Therapeutic areas: ImmunologyRheumatologyDermatologyOther
Modalities: Cell therapyStem cell therapyExosome-based therapy
Industry: Biotech

Beyond the preview

Go deeper on Qeen Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qeen Biotechnologies.

Explore the full profile